Skip to Main Content
Try STAT+ TODAY
Trending:
Health
STAT+
Biotech
Pharmalot
Subscribe Now To access exclusive content, subscribe to STAT+
View Latest View the latest STAT+ stories
Pharmalot
STAT+

Allergan and a Mohawk tribe ask the Supreme Court to review their controversial patent deal

  • Ed Silverman

By Ed Silverman Jan. 15, 2019

Reprints
Pfizer Allergan
Richard Drew/AP

File this under: “If at first you don’t succeed …”

After being rebuffed by a federal appeals court last summer, Allergan (AGN) and the St. Regis Mohawk Tribe have asked the U.S. Supreme Court to decide a vexing question that was at the heart of a controversial maneuver to protect a best-selling eye medicine.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

About the Author Reprints

Ed Silverman

Ed Silverman

Pharmalot Columnist, Senior Writer

Ed Silverman covers the pharmaceutical industry.

Tags

I was laid off from a public health job.…
I was laid off from a public health job. Trust me, tech layoffs are different
23andMe had devastating news about my health. I wish…
23andMe had devastating news about my health. I wish a person had delivered it
Why fentanyl is deadlier than heroin, in a single…
Why fentanyl is deadlier than heroin, in a single photo
Turkish court hands Novartis and Roche a rare win…
Turkish court hands Novartis and Roche a rare win over their efforts to promote an eye…
Up and down the ladder: The latest comings and…
Up and down the ladder: The latest comings and goings
Pharmalittle: ALS Association and its chapters battle over money…
Pharmalittle: ALS Association and its chapters battle over money and priorities; eye drops recalled over links…

Recommended Stories